Skip to main content

IP Alert: Which Patent Trial and Appeal Board Trial Decisions Cannot be Appealed?

NEWS -
Which Patent Trial and Appeal Board Trial Decisions Cannot be Appealed? By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit heard oral arguments on March 6, 2018, in the appeal of Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 2017-1487, from the post grant review (PGR) decision of the U.S. Patent and…

IP Alert: Inherency and Obviousness: Strange Bedfellows

NEWS -
  Inherency and Obviousness: Strange Bedfellows By Sarah A. Kagan The concept of disclosure by inherency exists in tension with the concept of obviousness. Inherency looks back at prior art and analyzes what was disclosed but unappreciated at that time. Obviousness looks at what a person of skill in the art knew at the time…

Banner & Witcoff, eight attorneys recognized for patent prosecution and litigation in 2018 IAM Patent 1000

NEWS -
Banner & Witcoff is recognized for patent prosecution and litigation in Illinois, and prosecution in Washington, D.C. in the 2018 edition of the IAM Patent 1000. Joseph J. Berghammer is recognized for prosecution in Illinois; John P. Iwanicki is recognized for prosecution in Massachusetts; Ross A. Dannenberg, Robert S. Katz, Frederic M. Meeker and Darrell G. Mottley are recognized for prosecution in…

IP Alert: Confidentiality Agreements Get Teeth

NEWS -
  Confidentiality Agreements Get Teeth By Sarah A. Kagan Do you consider Non-Disclosure Agreements (NDAs) and Material Transfer Agreements (MTAs) mere hoops to jump through before you can get what you really want? Do you think you can sign them and then forget about them, without a program to monitor and enforce compliance? If so,…

IP Alert: Capturing Inventions from FDA Label Changes

NEWS -
  Capturing Inventions from FDA Label Changes By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit on January 9, 2018, heard oral arguments in Praxair Distribution, Inc. v. Mallinckrodt Hospital Products, Fed. Cir. No. 2016-2616, -2656, involving an appeal and cross-appeal of an inter partes review (IPR) from the U.S. Patent…
Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page